English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/52876
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide

AuthorsForssmann, Wolf Georg; The, Yu-Han; Stoll, Matthias; Adermann, Knut; Albrecht, Uwe; Barlos, Kleomenis; Busmann, Annette; Canales, Ángeles ; Giménez-Gallego, Guillermo ; Hirsch, Jochen; Jiménez-Barbero, Jesús ; Meyer-Olson, Dirk; Münch, Jan; Pérez-Castells, Javier; Ständker, Ludger; Kirchhoff, Frank; Schmidt, Reinhold E.
Issue Date22-Dec-2010
PublisherAmerican Association for the Advancement of Science
CitationScience Translational Medicine; 2 (63) :63re3 (2010)
AbstractTo infect host cells, most enveloped viruses must insert a hydrophobic fusion peptide into the host cell membrane. Thus, fusion peptides may be valuable targets for developing drugs that block virus entry. We have shown previously that a natural 20-residue fragment of α1-antitrypsin, designated VIRus-Inhibitory Peptide (VIRIP), that binds to the gp41 fusion peptide of HIV-1 prevents the virus from entering target cells in vitro. Here, we examine the efficacy of 10-day monotherapy with the optimized VIR-576 derivative of VIRIP in treatment-naïve, HIV-1–infected individuals with viral RNA loads of ≥10,000 copies per ml. We report that at the highest dose (5.0 grams per day), intravenous infusion of VIR-576 reduced the mean plasma viral load by 1.23 log10 copies per ml without causing severe adverse effects. Our results are proof of concept that fusion peptide inhibitors suppress viral replication in human patients, and offer prospects for the development of a new class of drugs that prevent virus particles from anchoring to and infecting host cells
Description8 páginas, 3 figuras, 2 tablas -- p. 63re3
Publisher version (URL)http://dx.doi.org/10.1126/scitranslmed.3001697
URIhttp://hdl.handle.net/10261/52876
DOI10.1126/scitranslmed.3001697
ISSN1946-6234
E-ISSN1946-6242
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.